Award
NIH Reporter #1F31CA301949-01
The Development of Selective Inhibitors to Oncogenic Rac1 Variants
Recipient
Victoria Bowcut
Award Amount
$42,277.00
Ceiling
$42,277.00
Awarded
July 18, 2025
Identifier
1F31CA301949-01
NIH grant awarded for developing selective inhibitors targeting oncogenic Rac1 variants involved in cancer, using advanced molecular techniques.
Description
This is a NIH grant project focusing on developing chemical tools to target Rac1 variants involved in cancer. The project involves structure-based design, CRISPR Prime editing, and covalent inhibitor development.